Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission in...
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
About this item
Full title
Author / Creator
Verschueren, P , De Cock, D , Corluy, L , Joos, R , Langenaken, C , Taelman, V , Raeman, F , Ravelingien, I , Vandevyvere, K , Lenaerts, J , Geens, E , Geusens, P , Vanhoof, J , Durnez, A , Remans, J , Vander Cruyssen, B , Van Essche, E , Sileghem, A , De Brabanter, G , Joly, J , Meyfroidt, S , Van der Elst, K and Westhovens, R
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Objectives To compare the efficacy and safety of intensive combination strategies with glucocorticoids (GCs) in the first 16 weeks (W) of early rheumatoid arthritis (eRA) treatment, focusing on high-risk patients, in the Care in early RA trial. Methods 400 disease-modifying antirheumatic drugs (DMARD)-naive patients with eRA were recruited and stra...
Alternative Titles
Full title
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1634281293
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1634281293
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2014-205489
